Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2,6-Dihydroxybenzoic acid, a secondary metabolite derived from salicylic acid, undergoes hydrolyzation by liver enzymes as part of phase I metabolism.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
500 mg | 在庫あり | ¥ 10,000 | |||
5 g | 在庫あり | ¥ 11,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | 2,6-Dihydroxybenzoic acid, a secondary metabolite derived from salicylic acid, undergoes hydrolyzation by liver enzymes as part of phase I metabolism. |
分子量 | 154.12 |
分子式 | C7H6O4 |
CAS No. | 303-07-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (324.42 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
2,6-Dihydroxybenzoic acid 303-07-1 Metabolism Endogenous Metabolite 2,6 Dihydroxybenzoic acid 2,6Dihydroxybenzoic acid inhibit Inhibitor inhibitor